Opportunity ID: 329815

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-045
Funding Opportunity Title: Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 13, 2020
Last Updated Date: Nov 13, 2020
Original Closing Date for Applications: Nov 03, 2023
Current Closing Date for Applications: Nov 03, 2023
Archive Date: Dec 09, 2023
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Private institutions of higher education
Public and State controlled institutions of higher education
City or township governments
County governments
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-045.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 329815 Full Announcement-PAR-21-045 -> PAR-21-045-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00264076 Feb 04, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00270303 Nov 16, 2021 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278118 Nov 08, 2022 Nov 03, 2023 View

Package 1

Mandatory forms

329815 RR_SF424_2_0-2.0.pdf

329815 PHS398_CoverPageSupplement_5_0-5.0.pdf

329815 RR_OtherProjectInfo_1_4-1.4.pdf

329815 PerformanceSite_2_0-2.0.pdf

329815 RR_KeyPersonExpanded_2_0-2.0.pdf

329815 PHS398_ResearchPlan_4_0-4.0.pdf

329815 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

329815 RR_Budget_1_4-1.4.pdf

329815 RR_SubawardBudget30_1_4-1.4.pdf

329815 PHS398_ModularBudget_1_2-1.2.pdf

329815 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

329815 RR_SF424_5_0-5.0.pdf

329815 PHS398_CoverPageSupplement_5_0-5.0.pdf

329815 RR_OtherProjectInfo_1_4-1.4.pdf

329815 PerformanceSite_4_0-4.0.pdf

329815 RR_KeyPersonExpanded_4_0-4.0.pdf

329815 PHS398_ResearchPlan_4_0-4.0.pdf

329815 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

329815 RR_Budget_3_0-3.0.pdf

329815 RR_SubawardBudget30_3_0-3.0.pdf

329815 PHS398_ModularBudget_1_2-1.2.pdf

329815 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

329815 RR_SF424_5_0-5.0.pdf

329815 PHS398_CoverPageSupplement_5_0-5.0.pdf

329815 RR_OtherProjectInfo_1_4-1.4.pdf

329815 PerformanceSite_4_0-4.0.pdf

329815 RR_KeyPersonExpanded_4_0-4.0.pdf

329815 PHS398_ResearchPlan_5_0-5.0.pdf

329815 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

329815 RR_Budget_3_0-3.0.pdf

329815 RR_SubawardBudget30_3_0-3.0.pdf

329815 PHS398_ModularBudget_1_2-1.2.pdf

329815 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T17:56:27-05:00

Share This Post, Choose Your Platform!

About the Author: